Shire to use Nimbus platform in orphan-drug development

05/9/2013 | Xconomy

Shire announced plans to use Nimbus' discovery platform to develop an oral drug for lysosomal storage disorders. Nimbus will use its drug discovery software to screen molecules that could attack the disease, then Shire will conduct clinical trials and commercialize the product.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI